NEW YORK – With a fresh $121 million in financing from its recent Series A funding round, proteomics firm Somalogic is looking to expand its SomaScan platform business and continue its push into the diagnostics space.
The Boulder, Colorado-based company is working to make assays run on its SomaScan system more streamlined and cost-efficient and more easily deployable in sites like hospital labs while also continue to expand the menu of proteins the platform is able to measure, said CEO Roy Smythe.